147 related articles for article (PubMed ID: 17443226)
1. Janus kinase mutations in the development of acute megakaryoblastic leukemia in children with and without Down's syndrome.
Klusmann JH; Reinhardt D; Hasle H; Kaspers GJ; Creutzig U; Hahlen K; van den Heuvel-Eibrink MM; Zwaan CM
Leukemia; 2007 Jul; 21(7):1584-7. PubMed ID: 17443226
[No Abstract] [Full Text] [Related]
2. Megakaryoblastic leukemia and Down's syndrome: a review.
Zipursky A; Peeters M; Poon A
Pediatr Hematol Oncol; 1987; 4(3):211-30. PubMed ID: 2978961
[TBL] [Abstract][Full Text] [Related]
3. Origins of leukaemia in children with Down syndrome.
Hitzler JK; Zipursky A
Nat Rev Cancer; 2005 Jan; 5(1):11-20. PubMed ID: 15630411
[TBL] [Abstract][Full Text] [Related]
4. [Megakaryoblastic leukemia and transient abnormal myelopoiesis with Down's syndrome].
Suda J; Eguchi M
Rinsho Ketsueki; 1988 Aug; 29(8):1200-6. PubMed ID: 2974493
[No Abstract] [Full Text] [Related]
5. Acute megakaryoblastic leukemia in Down syndrome.
Hitzler JK
Pediatr Blood Cancer; 2007 Dec; 49(7 Suppl):1066-9. PubMed ID: 17943965
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of gene alterations in acute megakaryoblastic leukemia of Down's syndrome.
Hirose Y; Kudo K; Kiyoi H; Hayashi Y; Naoe T; Kojima S
Leukemia; 2003 Nov; 17(11):2250-2. PubMed ID: 12931214
[No Abstract] [Full Text] [Related]
7. [Acute megakaryoblastic leukemia in Down's syndrome following refractory anemia with excess of blasts].
Hayashi Y; Habu Y; Fujii Y; Hanada R; Yamamoto K; Nishida T; Eguchi M
Rinsho Ketsueki; 1986 Sep; 27(9):1650-5. PubMed ID: 2949094
[No Abstract] [Full Text] [Related]
8. Downs' syndrome with acute myeloid leukemia.
Tauro S
J Assoc Physicians India; 1995 Feb; 43(2):148. PubMed ID: 9282697
[No Abstract] [Full Text] [Related]
9. Chromosome copy number and leukemia-lessons from Down's syndrome.
Izraeli S
Hematology; 2005; 10 Suppl 1():164-6. PubMed ID: 16188662
[No Abstract] [Full Text] [Related]
10. Transient myelodysplasia in an infant with Down syndrome preceding acute megakaryoblastic leukemia: cytogenetic and immunophenotypic findings.
Rodrigues EF; da Costa ES; Land MG; Diamond HR; Ornellas MH; Abdelhay E; Fernandez Tde S
Cancer Genet Cytogenet; 2009 Jan; 188(1):54-6. PubMed ID: 19061782
[No Abstract] [Full Text] [Related]
11. Transient leukemia followed by megakaryoblastic leukemia in a child with mosaic Down syndrome.
Doyle JJ; Thorner P; Poon A; Tanswell K; Kamel-Reid S; Zipursky A
Leuk Lymphoma; 1995 Apr; 17(3-4):345-50. PubMed ID: 8580807
[TBL] [Abstract][Full Text] [Related]
12. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome.
Wechsler J; Greene M; McDevitt MA; Anastasi J; Karp JE; Le Beau MM; Crispino JD
Nat Genet; 2002 Sep; 32(1):148-52. PubMed ID: 12172547
[TBL] [Abstract][Full Text] [Related]
13. GATA1 as a new target to detect minimal residual disease in both transient leukemia and megakaryoblastic leukemia of Down syndrome.
Pine SR; Guo Q; Yin C; Jayabose S; Levendoglu-Tugal O; Ozkaynak MF; Sandoval C
Leuk Res; 2005 Nov; 29(11):1353-6. PubMed ID: 15916804
[TBL] [Abstract][Full Text] [Related]
14. Mutation characterization in the GATA-1 gene in patients with Down's Syndrome diagnosed with transient abnormal myelopoiesis or acute megakaryoblastic leukemia.
Mansini AP; Rubio PL; Rossi JG; Gallego MS; Medina A; Zubizarreta PA; Felice MS; Alonso CN
Arch Argent Pediatr; 2013 Dec; 111(6):532-6. PubMed ID: 24196768
[TBL] [Abstract][Full Text] [Related]
15. Development of acute megakaryoblastic leukemia from a minor clone in a Down syndrome patient with clinically overt transient myeloproliferative disorder.
Xu G; Kato K; Toki T; Takahashi Y; Terui K; Ito E
J Pediatr Hematol Oncol; 2006 Oct; 28(10):696-8. PubMed ID: 17023834
[TBL] [Abstract][Full Text] [Related]
16. High frequency of copy number alterations in myeloid leukaemia of Down syndrome.
Blink M; van den Heuvel-Eibrink MM; Aalbers AM; Balgobind BV; Hollink IH; Meijerink JP; van der Velden VH; Beverloo BH; de Haas V; Hasle H; Reinhardt D; Klusmann JH; Pieters R; Calado RT; Zwaan CM
Br J Haematol; 2012 Sep; 158(6):800-3. PubMed ID: 22775985
[No Abstract] [Full Text] [Related]
17. [Congenital acute megakaryoblastic leukemia associated with trisomy 21].
Gomis F; Pérez Sirvent ML; Borrego D; Sempere A
Sangre (Barc); 1990 Dec; 35(6):485-6. PubMed ID: 2150895
[No Abstract] [Full Text] [Related]
18. JAK3 mutations occur in acute megakaryoblastic leukemia both in Down syndrome children and non-Down syndrome adults.
Kiyoi H; Yamaji S; Kojima S; Naoe T
Leukemia; 2007 Mar; 21(3):574-6. PubMed ID: 17252020
[No Abstract] [Full Text] [Related]
19. [The molecular mechanism of leukemogenesis in Down syndrome-related acute megakaryocytic leukemia].
Ito E; Toki T
Nihon Rinsho; 2007 Jan; 65 Suppl 1():136-40. PubMed ID: 17476742
[No Abstract] [Full Text] [Related]
20. Down syndrome and GATA1-related transient leukemia.
Sandoval C; Pine SR
J Pediatr; 2007 Mar; 150(3):e34. PubMed ID: 17307526
[No Abstract] [Full Text] [Related]
[Next] [New Search]
